Notice Number: NOT-NS-18-028
Release Date: December 14, 2017
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this Notice is to revise the NINDS interest statement for PAR-18-206.
The current language reads:
NINDS: NINDS will not accept applications under this announcement that include clinical trials (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-015.html). A clinical trial is a prospective biomedical or behavioral research study of human subjects designed to answer specific questions about safety, tolerability, efficacy and/or effectiveness of pharmacologic, behavioral, biologic, surgical, or device (invasive or non-invasive) interventions. Other human subjects research can be submitted and NINDS may decline funding of any application that includes human subjects for programmatic or administrative reasons. Applicants considering projects involving human subjects research are strongly encouraged to contact Scientific/Research staff.
Applications proposing non-clinical studies concluding in a clinical trial should be submitted to one of the following NINDS CREATE Devices FOAs specifically designed for pre-clinical and pilot clinical studies for therapeutic devices (http://www.ninds.nih.gov/funding/areas/translational_research/CREATE-Devices.htm).
Applications proposing a clinical trial must be submitted to one of the following NINDS FOAs specifically designed for clinical trials (http://www.ninds.nih.gov/research/clinical_research/index.htm#tab3-panel)
The language has been modified and now reads:
Part 2. Full Text of Announcement
NINDS: Within the goals of this FOA, NINDS is particularly interested in bioengineering research that advances technologies with the potential to decrease the burden of neurological disorders and stroke. Examples of areas of interest include the development and validation of invasive and non-invasive devices, diagnostic/monitoring tools, advanced imaging techniques, computational models, tissue engineering, and other innovative methods. Applicants are strongly encouraged to contact NINDS Scientific Program staff prior to submission. Applicants interested in translational activities and clinical studies of therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems may be more appropriate for other NINDS bioengineering opportunities (https://www.ninds.nih.gov/Current-Research/Focus-Research/Focus-Bioengineering-Research).
All other aspects of this FOA remain unchanged.
Please direct all inquiries to:
Nick Langhals, Ph.D.
National Institute of Neurological Disorders and Stroke